Factor xiii anti-hem factor
Products billed under this code include Corifact.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Corifact.
Payment limit per 1 IU, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Corifact | CSL Behring L.L.C. | 63833-0518-02 | 1 | $11.239 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $11.239 | +$0.004 | 1 IU | Factor xiii anti-hem factor | v1, posted September 17, 2026 |
| 3Q26 | $11.235 | +$0.457 | 1 IU | Factor xiii anti-hem factor | v1, posted September 15, 2026 |
| 2Q26 | $10.778 | +$0.015 | 1 IU | Factor xiii anti-hem factor | v1, posted September 15, 2026 |
| 1Q26 | $10.763 | +$0.007 | 1 IU | Factor xiii anti-hem factor | v1, posted September 15, 2026 |
| 4Q25 | $10.756 | −$0.023 | 1 IU | Factor xiii anti-hem factor | v1, posted September 8, 2026 |
| 3Q25 | $10.779 | +$0.302 | 1 IU | Factor xiii anti-hem factor | v1, posted March 10, 2026 |
| 2Q25 | $10.477 | +$0.004 | 1 IU | Factor xiii anti-hem factor | v1, posted March 10, 2026 |
| 1Q25 | $10.473 | +$0.314 | 1 IU | Factor xiii anti-hem factor | v1, posted December 19, 2025 |
| 4Q24 | $10.159 | +$0.005 | 1 IU | Factor xiii anti-hem factor | v1, posted June 11, 2025 |
| 3Q24 | $10.154 | $0.00 | 1 IU | Factor xiii anti-hem factor | v1, posted June 11, 2025 |
| 2Q24 | $10.154 | +$0.478 | 1 IU | Factor xiii anti-hem factor | v1, posted March 11, 2025 |
| 1Q24 | $9.676 | +$0.003 | 1 IU | Factor xiii anti-hem factor | v1, posted December 19, 2024 |
| 4Q23 | $9.673 | −$0.01 | 1 IU | Factor xiii anti-hem factor | v1, posted October 10, 2024 |
| 3Q23 | $9.683 | −$0.005 | 1 IU | Factor xiii anti-hem factor | v1, posted June 5, 2024 |
| 2Q23 | $9.688 | +$0.273 | 1 IU | Factor xiii anti-hem factor | v1, posted February 23, 2024 |
| 1Q23 | $9.415 | +$0.011 | 1 IU | Factor xiii anti-hem factor | v1, posted December 6, 2023 |
| 4Q22 | $9.404 | +$0.034 | 1 IU | Factor xiii anti-hem factor | v1, posted June 22, 2023 |
| 3Q22 | $9.37 | −$0.008 | 1 IU | Factor xiii anti-hem factor | v1, posted June 9, 2023 |
| 2Q22 | $9.378 | +$0.243 | 1 IU | Factor xiii anti-hem factor | v1, posted December 14, 2022 |
| 1Q22 | $9.135 | −$0.006 | 1 IU | Factor xiii anti-hem factor | v1, posted June 8, 2022 |
| 4Q21 | $9.141 | +$0.015 | 1 IU | Factor xiii anti-hem factor | v1, posted June 2, 2022 |
| 3Q21 | $9.126 | +$0.022 | 1 IU | Factor xiii anti-hem factor | v1, posted June 2, 2022 |
| 2Q21 | $9.104 | +$0.321 | 1 IU | Factor xiii anti-hem factor | v1, posted March 1, 2022 |
| 1Q21 | $8.783 | – | 1 IU | Factor xiii anti-hem factor | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.